Company Filing History:
1 out of 2,077 
1 out of 76 Years Active: 2002-2007
Title: Yu Kai Lee: Innovator in Thrombin Modulation
Introduction
Yu Kai Lee is a notable inventor based in Exton, PA (US), recognized for his contributions to the field of pharmaceutical sciences. He holds 2 patents that focus on innovative compounds and methods aimed at addressing thrombin-related diseases.
Latest Patents
His latest patents include "Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls." This invention describes compounds of Formula I or a pharmaceutically acceptable salt thereof, intended for the prophylaxis or treatment of diseases and conditions related to thrombin activity in mammals. Additionally, it relates to a novel method of N-oxidation of nitrogen-containing heteroaryls. Another significant patent is "Tyrosine alkoxyguanidines as integrin inhibitors," which further showcases his innovative approach to pharmaceutical development.
Career Highlights
Throughout his career, Yu Kai Lee has worked with prominent companies such as Janssen Pharmaceutica and 3-Dimensional Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Yu Kai Lee has collaborated with notable professionals in his field, including Kevin Douglas Kreutter and Tianbao Lu. These collaborations have likely enhanced his research and development efforts.
Conclusion
Yu Kai Lee's work in thrombin modulation and integrin inhibition highlights his significant contributions to pharmaceutical innovation. His patents reflect a commitment to advancing medical science and improving treatment options for various conditions.